Illumina Q4 rev $1.115B (+3%), FY rev $4.497B (-2%); shipped 352 NovaSeq X in FY23

ILLUMINA, INC.

2023-FY EPS reported -$7.34 revenue$4,504,000,000

Consolidated revenue $1,115M Q4 (+3% YoY); full-year $4,497M (-2% YoY).
Core Illumina revenue $1,090M Q4 (+2%); full-year $4,431M (-3%).
Shipped 79 NovaSeq X instruments in Q4 and 352 in fiscal 2023.
Consolidated GAAP operating margin (15.5%) Q4, (24.0%) FY; non-GAAP margins 3.8% and 5.3%.
Preliminary results subject to adjustment; full Q4/FY results due Feb 8, 2024.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

ILLUMINA, INC. reported preliminary financial results for the fourth quarter and fiscal year ended December 31, 2023.

Period: the fourth quarter and fiscal year ended December 31, 2023
Result: preliminary results

Exact text from the filing

Illumina Announces Preliminary Financial Results for Fourth Quarter and Fiscal Year 2023

View on SEC.gov

10 earnings releases filed in the last 30 days. Browse all earnings releases →

ILLUMINA, INC. filing history →

Source: SEC EDGAR

accession 0001110803-24-000002

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.